Endobrevin/VAMP-8–dependent dense granule release mediates thrombus formation in vivo

GJ Graham, Q Ren, JR Dilks, P Blair… - Blood, The Journal …, 2009 - ashpublications.org
GJ Graham, Q Ren, JR Dilks, P Blair, SW Whiteheart, R Flaumenhaft
Blood, The Journal of the American Society of Hematology, 2009ashpublications.org
Individuals whose platelets lack dense or α-granules suffer various degrees of abnormal
bleeding, implying that granule cargo contributes to hemostasis. Despite these clinical
observations, little is known regarding the effects of impaired platelet granule secretion on
thrombus formation in vivo. In platelets, SNARE proteins mediate the membrane fusion
events required for granule cargo release. Endobrevin/VAMP-8 is the primary vesicle-
SNARE (v-SNARE) responsible for efficient release of dense and α-granule contents; thus …
Individuals whose platelets lack dense or α-granules suffer various degrees of abnormal bleeding, implying that granule cargo contributes to hemostasis. Despite these clinical observations, little is known regarding the effects of impaired platelet granule secretion on thrombus formation in vivo. In platelets, SNARE proteins mediate the membrane fusion events required for granule cargo release. Endobrevin/VAMP-8 is the primary vesicle-SNARE (v-SNARE) responsible for efficient release of dense and α-granule contents; thus, VAMP-8−/− mice are a useful model to evaluate the importance of platelet granule secretion in thrombus formation. Thrombus formation, after laser-induced vascular injury, in these mice is delayed and decreased, but not absent. In contrast, thrombus formation is almost completely abolished in the mouse model of Hermansky-Pudlak syndrome, ruby-eye, which lacks dense granules. Evaluation of aggregation of VAMP-8−/− and ruby-eye platelets indicates that defective ADP release is the primary abnormality leading to impaired aggregation. These results demonstrate the importance of dense granule release even in the earliest phases of thrombus formation and validate the distal platelet secretory machinery as a potential target for antiplatelet therapies.
ashpublications.org